0.264
-0.02 (-7.38%)
| Penutupan Terdahulu | 0.285 |
| Buka | 0.280 |
| Jumlah Dagangan | 254,693 |
| Purata Dagangan (3B) | 1,384,059 |
| Modal Pasaran | 48,303,116 |
| Harga / Jualan (P/S) | 0.670 |
| Harga / Buku (P/B) | 28.85 |
| Julat 52 Minggu |
| Margin Keuntungan | -159.10% |
| Margin Operasi (TTM) | -155.29% |
| EPS Cair (TTM) | -0.610 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 42.70% |
| Nisbah Semasa (MRQ) | 0.140 |
| Aliran Tunai Operasi (OCF TTM) | 11.43 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 32.73 M |
| Pulangan Atas Aset (ROA TTM) | -57.16% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - General (US) | Menaik | Menaik |
| Drug Manufacturers - General (Global) | Menaik | Menaik | |
| Stok | Scilex Holding Company | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.00 |
|
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - General |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 25.93% |
| % Dimiliki oleh Institusi | 20.34% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Murchinson Ltd. | 31 Dec 2024 | 663,705 |
| Rafferty Asset Management, Llc | 31 Dec 2024 | 620,131 |
| Julat 52 Minggu | ||
| Median | 18.00 (6,728.53%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| D. Boral Capital | 02 Apr 2025 | 18.00 (6,728.53%) | Beli | 0.298 |
| 28 Feb 2025 | 22.00 (8,245.98%) | Beli | 0.236 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |